Therapy of Epilepsy Flashcards

1
Q

What happens in epilepsy?

A

Disrupted regulation of electrical activity in the brain = Synchronized and excessive neuronal discharge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is critical to selection of appropriate pharmacotherapy for epilepsy?

A

Accurate classification and diagnosis of seizure type, including mode of seizure onset.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Aims of Drug therapy in Epilepsy?

A

1) Reducing the frequency of seizures
2) Minimizing adverse effects of anti-seizure drugs
3) Addressing coexisting health and social conditions
4) Enhancing quality of life (QOL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Seizures that do NOT constitute epilepsy are those provoked by:

A

1) Infections
2) Fever (febrile seizures)
3) Drug overdose
4) Alcohol
5) Barbiturate or benzodiazepine withdrawal
6) Brain hemorrhage
7) Hypocalcemia
8) Hypoglycemia
9) Uremia
10) Eclampsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the mainstay of epilepsy treatment?

A

Anti-seizure drug (ASD) therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Are Anti-seizure drugs (ASD) curative?

A

No, symptomatic and preventative only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How long are ASDs taken for?

A

Life-long

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do you do if the therapeutic goal for epilepsy is NOT achieved with monotherapy?

A

1) Add a second antiseizure drug (ASD), with a different mechanism of action
2) Switch to an alternative single ASD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What should you emphasize in epilepsy treatment?

A

Treat with a single drug!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does the epilepsy drug treatment of first-choice depend on?

A

1) Type of epilepsy
2) Patient characteristics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What should you do once the proper ASD is selected?

A

Patient education and understanding of the treatment plan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the single most common reason for ASD treatment failure?

A

Medication non-adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Up to __% of patients with epilepsy are nonadherent to therapy.

A

60%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Reasons for ASD non-adherence:

A

1) Financial constraints
2) Complexity of the drug regimen
3) Frequent uncontrolled seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How should you stop ASD treatment?

A

Gradually, in order to avoid recurrence of seizures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sudden ASD withdrawal can be associated with:

A

Status Epilepticus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Withdrawal seizures are more common with which drugs?

A

1) Benzodiazepines
2) Barbiturates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which patient characteristics must be considered before starting ASD treatment?

A

1) Age
2) Gender
3) Medical conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What should we keep in mind when giving ASDs to children?

A

They are more susceptible to neuropsychiatric adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What should we keep in mind when giving ASDs to Women of child-bearing potential?

A

They should not receive teratogenic ASDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What should we keep in mind when giving ASDs to the elderly?

A

They are more susceptible to adverse effects on cognition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What if a patient has co-morbid conditions (migraine, tremor, or neuropathy)?

A

They may benefit from the use of an ASD that can also treat the
other condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What should you pay EXTREME attention to when giving ASDs?

A

1) Drug-drug interactions with other drugs
2) Drug-drug interactions among ASDs themselves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the steps when giving ASDs?

A

1) Select one ASD, start with a low dose, and gradually titrate to a moderate dose goal, taking into account the patient’s response to treatment.

2) If there is NO adequate response at that dose, attempt increasing the dose.

3) If the first ASD monotherapy is still ineffective, or if the patient experiences intolerable adverse effects, adding a second ASD with a different mechanism of action and then tapering and discontinuing the first ASD is appropriate.

4) If the second ASD is ineffective, combination therapy may be indicated (although NOT
desirable).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

A patient takes 1 ASD at a moderate dose, yet there is no therapeutic response. What is the next step?

A

Increase the dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

A patient takes 1 ASD at a moderate dose, yet has extreme side effects. What is the next step?

A

Add a second ASD with a different mechanism of action, then slowly taper off the first ASD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

A patient takes 1 ASD at a high dose and has previously tried 2 other ASDs, yet there is still no response. What is the next step?

A

ASD combination therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

You have an elderly patient who is sensitive to falls, sedation, and neuro-cognitive adverse effects. How do you start ASD therapy?

A

Start at much lower initial dose and then titrate slowly (weeks –months), with a lower maximum dose goal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

You have a patient with multiple recent seizures (higher frequency). How do you start ASD therapy?

A

A therapeutic dose needs to be reached much more quickly, and a more rapid titration over days instead of weeks is appropriate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Which ASDs have strong enough evidence to be labeled as effective, or as probably effective as initial monotherapy in certain seizure types?

A

1) Carbamazepine
2) Ethosuximide
3) Gabapentin
4) Levetiracetam
5) Oxcarbazepine
6) Phenytoin
7) Valproic acid
8) Zonisamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

ASD resistance is defined as:

A

Failure of two tolerated and appropriately chosen ASD (as monotherapy or in combination) to achieve sustained seizure freedom.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Approximately 65% of patients can be maintained on one ASD and considered well controlled, although NOT necessarily ____.

A

Seizure free

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

The percentage of patients who are seizure-free on one drug after 12 months of treatment for only generalized tonic-clonic seizures is:

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

The percentage of patients who are seizure-free on one drug after 12 months of treatment for only focal seizures is:

A

25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

The percentage of patients who are seizure-free on one drug after 12 months of treatment for those with mixed seizure types is:

A

25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Of the 35% of patients with unsatisfactory control on monotherapy, __% will be well
controlled with a two-drug combination.

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

____ are common and serious complicating factor in ASD selection.

A

Pharmacokinetic interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Which ASD drugs are considered enzyme inducers?

A

1) Carbamazepine
2) Lamotrigine
3) Phenytoin
4) Phenobarbital
5) Vigabatrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Which ASD drugs are considered enzyme inhibitors?

A

1) Valproic acid
2) Topiramate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Knowledge of the presence of ____ of ASDs is important as they affect duration of action of the drug.

A

Active metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Why is knowledge of the presence of active metabolites of ASDs important?

A

They affect duration of action of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Which ASDs have active metabolites?

A

1) Carbamazepine
2) Primidone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Which ASDs have toxic metabolites?

A

Valproic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What are some common adverse effects shared by ASDs?

A

1) CNS adverse effects:
a) Sedation
b) Dizziness
c) Blurred or double vision
d) Difficulty in concentration
e) Ataxia

2) Impairment of cognition

3) Osteomalacia and osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Which ASD causes more cognitive impairment than any other ASDs?

A

Barbiturates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What do barbiturates do in children?

A

Paradoxically cause hyperactivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Which newer ASD causes substantial cognitive impairment?

A

Topiramate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

How can ASD adverse effects be avoided?

A

By titrating the dose upward very slowly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

How can ASD adverse effects be improved?

A

1) By decreasing the dose
2) By switching from polytherapy to monotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Which ASDs interfere with vitamin D metabolism and/or absorption?

A

1) Phenytoin
2) Phenobarbital
3) Carbamazepine
4) Oxcarbazepine
5) Valproic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Patients receiving ASDs that interfere with Vitamin D metabolism/absorption should also receive:

A

1) Supplemental vitamin D and calcium
2) Bone mineral density testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Why do we monitor the older ASDs?

A

To optimize therapy for an individual patient !NOT!! as a therapeutic end point in itself!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

The serum concentration of ASDs should be always interpreted in association with:

A

Clinical response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Which seizure type needs higher concentrations of ASDs?

A

Focal dyscognitive seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Serum levels can also be useful:

A

1) To document lack or loss of efficacy
2) To document non-adherence
3) To determine how much room there is to increase a dose based on expected toxicity
4) In patients with significant renal or hepatic dysfunction
5) In those taking multiple drugs
6) In women who are pregnant or taking OCPs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

When should ASD monitoring be performed?

A

ONLY at steady-state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

What is Carbamazepine’s active metabolite?

A

10,11-epoxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

What is Clobazam’s active metabolite?

A

N-desmethylclobazam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

What is Eslicarbazepine’s active metabolite?

A

Oxcarbazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What is Ezogabine’s active metabolite?

A

N-acetyl metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

What is Oxcarbazepine’s active metabolite?

A

10-hydroxycarbazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

What is Primidone’s active metabolite?

A

Phenobarbital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Which 4 ASDs are highly protein bound?

A

1) Perampanel
2) Phenytoin
3) Tiagabine
4) Valproic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Clinical response is more important than the serum drug concentrations and involves:

A

1) Identifying the type and number of seizures
2) Identifying drug adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Evaluation of therapeutic outcomes includes:

A

1) Clinical response

2) Severity and frequency of seizures

3) Ascertain if the patient is truly seizure free

4) Monitor patient long-term for co-morbid conditions, social adjustment (including Quality-Of-Life assessments), drug interactions, and adherence.

5) Screen periodically for co-morbid neuropsychiatric disorders (depression and
anxiety).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

The most important aspect of ASD use is:

A

Individualization of therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

The following should be considered together in personalized pharmacotherapy:

A

1) Seizure type
2) Concomitant medical problems (hepatic function, renal function, psychiatric diseases, other neurologic problems, …).
3) Concurrent medications
4) Patient specific characteristics (age, gender, child-bearing ability, and ethnicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

The elderly are often on polytherapy which may contribute to:

A

1) Increased sensitivity to neuro-cognitive effects
2) Increased possibility of drug-drug interactions with ASDs that affect CYP450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Which ASDs affect CYP450?

A

1) Carbamazepine
2) Phenytoin
3) Valproic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

What should we consider when giving drugs to the elderly?

A

1) They are often on polytherapy
2) Hypoalbuminemia
3) Body mass changes
4) Compromised renal or hepatic function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Why is hypoalbuminemia an issue when giving ASDs?

A

Because it may cause problems with highly protein bound ASDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Why are body mass changes (increase in fat to lean body mass or decrease in body water) an issue when giving ASDs?

A

They can affect the drug volume of distribution and elimination half-life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Which ASD is considered the medication of choice in the elderly?

A

Lamotrigine

74
Q

Why is Lamotrigine considered the medication of choice in the elderly?

A

Because it has equal efficacy to carbamazepine and gabapentin, and is better tolerated

75
Q

What can change the volume of distribution in neonates and infants?

A

1) Increase in the total body water to fat ratio
2) Decrease in serum albumin and α1-acid glycoprotein

76
Q

Children up to the age of 3 years have decreased ____ of ASDs, especially in neonates.

A

Renal elimination

77
Q

Is hepatic activity higher or lower than adults in neonates?

A

Lower

78
Q

Is hepatic activity higher or lower than adults in children (>2 years)?

A

Higher

79
Q

Does a 4 year old child need higher or lower ASD dosing compared to adults?

A

Higher

80
Q

Does an infant need higher or lower ASD dosing compared to adults?

A

Lower

81
Q

What are “Catamenial seizures”?

A

Seizures that happen:
1) Just before menstruation
2) During menstruation
3) At the time of ovulation

82
Q

What can cause “Catamenial seizures”?

A

1) Slight increase of estrogen relative to progesterone
2) Progesterone withdrawal

83
Q

Treatment of “Catamenial seizures”?

A

Conventional ASDs

84
Q

When do seizures tend to improve in women?

A

Menopause

85
Q

How do enzyme-inducing ASDs cause menstrual irregularity, infertility, sexual dysfunction, and polycystic ovarian syndrome (PCOS)?

A

1) By increasing the metabolism
of estrogen, progesterone, and testosterone
2) By increasing production of sex hormone binding globulin = decreases the free fraction of these hormones

86
Q

What are the ASD hormonal adverse effects in women?

A

1) Menstrual irregularity
2) Infertility
3) Sexual dysfunction
4) Polycystic ovarian syndrome (PCOS)

87
Q

Why shouldn’t women take enzyme-inducing ASDs with OCPs?

A

Leads to OCP failure due to increased metabolism of ethinyl estradiol (and progestin).

88
Q

____ may affect sex hormone concentrations, causing hyper-androgenism and polycystic changes.

A

Valproic acid

89
Q

Men with epilepsy have reduced ___.

A

Fertility

90
Q

Which ASDs are associated with sperm abnormalities in men?

A

1) Carbamazepine
2) Oxcarbazepine
3) Valproic acid

91
Q

Which ASD is associated with testicular atrophy (=reduced testosterone levels) in men?

A

Valproic acid

92
Q

True or False: ASDs have no affect on libido and sexual function in both men and women.

A

FALSE; they have an effect in both.

93
Q

Carbamazepine mechanism of action?

A

Enhances fast inactivation of voltage-gated Na+ channels.

94
Q

Carbamazepine’s place in therapy?

A

FIRST-LINE in many seizure types:
focal onset seizures, generalized tonic-clonic seizures, and mixed seizure types.

95
Q

Carbamazepine should NOT be given in which type of seizure?

A

Absence seizures

96
Q

Carbamazepine induces the metabolism of:

A

1) Primidone
2) Phenytoin
3) Ethosuximide
4) Valproic acid
5) Clonazepam

97
Q

Which drugs decrease the steady-state concentration of Carbamazepine by enzyme induction?

A

1) Phenytoin
2) Phenobarbital

98
Q

Which drugs inhibit Carbamazepine clearance and increase its steady-state levels?

A

1) Propoxyphene
2) Troleandomycin
3) Valproic acid

99
Q

Which enzyme, if inhibited, may potentially increase Carbamazepine serum concentrations?

A

CYP3A4

100
Q

Which Carbamazepine adverse reactions are concentration-dependent?

A

1) Diplopia
2) Dizziness
3) Unsteadiness
4) Drowsiness
5) Nausea

101
Q

Which Carbamazepine adverse reactions are idiosyncratic?

A

1) Blood dyscrasias
2) Steven-Johnson syndrome
3) Epidermal necrolysis

102
Q

Which Carbamazepine adverse reactions are chronic?

A

1) Hyponatremia
2) Metabolic bone disease

103
Q

What should you monitor with chronic use of Carbamazepine?

A

Serum calcium and Vitamin D

104
Q

Phenytoin mechanism of action?

A

Inhibits voltage-gated Na+ channels

105
Q

Phenytoin’s place in therapy?

A

1) Focal onset seizures
2) Generalized tonic-clonic seizures

106
Q

What does giving Phenytoin at very high concentrations (>50
µg/mL) do?

A

Exacerbates seizures

107
Q

What should you know when
interpreting serum phenytoin concentrations?

A

1) The patient’s serum albumin level
2) Renal function

108
Q

Phenytoin distributes to:

A

Breast milk

109
Q

Does Phenytoin cross the placenta?

A

YES

110
Q

Phenytoin displays ___ pharmacokinetics, (or zero-order kinetics).

A

Michaelis–Menten

111
Q

Phenytoin displays __(zero/first) order kinetics.

A

Zero

112
Q

Phenytoin is an inducer of:

A

1) CYP450
2) UGT isozymes

113
Q

What do UGT isozymes do?

A

Conjugate drugs with glucuronic acid

114
Q

Phenytoin ___(increases/decreases) folic acid absorption.

A

Decreases

115
Q

Should you give folic acid supplementation with Phenytoin? Why or why not?

A

No, it can reduce Phenytoin concentration and result in loss of efficacy.

116
Q

Which drugs can displace phenytoin from binding sites on plasma proteins?

A

1) Phenylbutazone
2) Sulfonamides

117
Q

Does hypoalbuminemia result in decreased total plasma drug concentration or free concentration of Phenytoin?

A

Total plasma drug concentration

118
Q

In which 2 cases should total Phenytoin levels NOT be increased due to fear of intoxication?

A

1) When taking Phenylbutazone or Sulfonamides
2) Hypoalbuminemia

119
Q

Which drugs induce the
metabolism of phenytoin?

A

1) Phenobarbital
2) Carbamazepine

120
Q

Which drug inhibits the metabolism of phenytoin?

A

Isoniazid

121
Q

Which Phenytoin adverse reactions are concentration-dependent?

A

1) Diplopia
2) Blurring of vision
3) Nystagmus
4) Ataxia
5) Dizziness
6) Somnolence
7) Incoordination
8) Sedation
9) Behavioral changes
10) Cognitive impairment
11) Fatigue

122
Q

Which Phenytoin adverse reactions are idiosyncratic?

A

1) Blood dyscrasias
2) Steven-Johnson syndrome
3) Epidermal necrolysis
4) Pseudolymphoma

123
Q

Which Phenytoin adverse reactions are chronic?

A

1) Cerebellar syndrome
2) Connective tissue changes
3) Skin thickening
4) Folate deficiency
5) Gingival hyperplasia
6) Hirsutism
7) Coarsening of facial features
8) Acne
9) Metabolic bone disease

124
Q

Valproic acid mechanism of action?

A

May potentiate postsynaptic GABA responses

125
Q

Valproic acid place in therapy?

A

1) First-line therapy for generalized seizures, including myoclonic, atonic, and absence seizures.
2) Migraine headaches
3) Bipolar disorders

126
Q

The primary pathway of valproic acid metabolism is:

A

β-oxidation, then glucuronidation

127
Q

What is Valproic acid’s metabolite?

A

4-ene-VPA

128
Q

Valproic acid is toxic with enzyme ____(inducing/inhibiting) drugs.

A

Enzyme-inducing

129
Q

4-ene-VPA can cause:

A

Hepatotoxicity

130
Q

Is Valproic acid teratogenic?

A

Yes, it crosses the placenta

131
Q

Which drugs fight for plasma proteins with Valproic acid?

A

1) Free fatty acids
2) Phenytoin
3) Aspirin

132
Q

Valproic acid inhibits which enzymes?

A

1) CYP450 isozymes
2) Epoxide hydrolase
3) UGT isozymes

133
Q

Valproic acid inhibits the metabolism of:

A

1) Phenobarbital
2) Phenytoin
3) Carbamazepine
4) Lamotrigine

134
Q

Oral contraceptives may ___(decrease/increase) the clearance of valproic acid .

A

Increase

135
Q

Meropenem can __(decrease/increase) valproic acid levels

A

Decrease

136
Q

Which Valproic acid adverse reactions are concentration-dependent?

A

1) GI upset
2) Sedation
3) Unsteadiness
4) Tremor
5) Thrombocytopenia

137
Q

Which Valproic acid adverse reactions are idiosyncratic?

A

1) Acute hepatic failure
2) Acute pancreatitis
3) Alopecia

138
Q

Which Valproic acid adverse reactions are chronic?

A

1) Polycystic ovary syndrome
2) Weight gain
3) Menstrual cycle irregularities
4) Hyperammonemia

139
Q

Ethosuximide mechanism of action?

A

Inhibition of T-type Ca2+ channels

140
Q

Ethosuximide’s place in therapy?

A

First-line treatment for absence seizures

141
Q

Ethosuximide has a __(narrow/wide) spectrum of activity.

A

Narrow

142
Q

Which Ethosuximide adverse reactions are concentration-dependent?

A

1) Ataxia
2) Drowsiness
3) GI upset
4) Unsteadiness
5) Hiccoughs

143
Q

___ may inhibit Ethosuximide’s metabolism.

A

Valproic acid

144
Q

Which Ethosuximide adverse reactions are idiosyncratic?

A

1) Blood dyscrasia
2) Rash

145
Q

Which Ethosuximide adverse reactions are chronic?

A

1) Behavioral changes
2) Headache

146
Q

Lamotrigine mechanism of action?

A

1) Inhibits voltage-gated Na+ channels
2) Modulates high voltage-gated Ca2+ channels
3) Modulates hyperpolarization-activated cation channels
4) Attenuates release of glutamate and to a lesser extent, GABA and dopamine.

147
Q

Lamotrigine place in therapy?

A

1) Monotherapy and adjunctive treatment in patients with focal onset seizures, as a first- or
second-line therapy.

2 Used in primary generalized tonic-clonic seizures and for primary generalized seizures of Lennox-Gastaut Syndrome (LGS)

148
Q

Lamotrigine’s half-life is prolonged in:

A

Renal failure

149
Q

Is Lamotrigine dialyzable?

A

YES

150
Q

___ inhibits Lamotrigine’s metabolism.

A

Valproic acid

151
Q

___ increases Lamotrigine’s CNS adverse effects.

A

Carbamazepine

152
Q

Why do oral contraceptives reduce Lamotrigine’s serum concentrations?

A

Because of induction of glucuronidation by ethinyl estradiol

153
Q

Which Lamotrigine adverse reactions are concentration-dependent?

A

1) Diplopia
2) Dizziness
3) Unsteadiness
4) Headache

154
Q

Which Lamotrigine adverse reactions are idiosyncratic?

A

1) Generalized erythematous and morbilliform rash
2) Steven-Johnson syndrome

155
Q

Topiramate inhibits which enzymes?

A

1) Carbonic anhydrase
2) CYP2C19

156
Q

Topiramate place in therapy?

A

1) Monotherapy or adjunctive therapy for focal onset seizures in patients 2 years or
older.

2) Tonic–clonic seizures in primary generalized epilepsy and generalized seizures in
patients with Lennox-Gastaut Syndrome (LGS).

3) Benefits patients with co-morbidities (migraines, obesity).

157
Q

Topiramate increases ___ serum concentrations due to inhibition of CYP2C19.

A

Phenytoin

158
Q

Topiramate may increase the clearance of ___ and the formation of its metabolites.

A

Valproic acid

159
Q

Topiramate increases the clearance of ___ at doses higher than 200 mg/day.

A

Ethinyl estradiol

160
Q

Topiramate should be adjusted in:

A

Renal impairment

161
Q

Which Topiramate adverse reactions are concentration-dependent?

A

1) Difficulty concentrating
2) Psychomotor slowing
3) Speech or language problems
4) Somnolence
5) Fatigue
6) Dizziness
7) Headache

162
Q

Which Topiramate adverse reactions are idiosyncratic?

A

1) Metabolic acidosis
2) Acute glaucoma
3) Oligohydrosis (deficient sweating)

163
Q

Which Topiramate adverse reactions are chronic?

A

1) Kidney stones
2) Weight loss

164
Q

Gabapentin mechanism of action?

A

1) Elevates human brain GABA levels
2) Binds to the α2δ subunit of Ca2+ channels = analgesic effects

165
Q

Gabapentin’s place in therapy?

A

1) Focal-onset seizures with or without secondary generalization in patients 3 years and older.

2) Useful in treating epilepsies with neuropathic pain.

166
Q

Which Gabapentin adverse reactions are concentration-dependent?

A

1) Dizziness
2) Somnolence
3) Fatigue
4) Ataxia

167
Q

Bioavailability of Gabapentin is reduced 20% by:

A

Aluminum antacids

168
Q

Which Gabapentin adverse reactions are idiosyncratic?

A

Pedal edema

169
Q

Which Gabapentin adverse reactions are chronic?

A

Weight gain

170
Q

Levetiracetam mechanism of action?

A

Binds to synaptic vesicle protein SV2A in presynaptic terminals and inhibits neurotransmitter release.

171
Q

Levetiracetam’s place in therapy?

A

Adjunctive therapy in focal-onset seizures in patients 12 years of age or older, myoclonic seizures, and primary generalized seizures

172
Q

Levetiracetam is mainly eliminated by:

A

Kidneys

173
Q

Levetiracetam’s dose should be reduced by 50% in:

A

Severe liver cirrhosis

174
Q

Levetiracetam is significantly excreted into:

A

Breast milk

175
Q

Which Levetiracetam adverse reactions are concentration-dependent?

A

1) Sedation
2) Behavioral disturbances

176
Q

Which Levetiracetam adverse reactions are idiosyncratic?

A

Psychosis

177
Q

Zonisamide mechanism of action?

A

1) Inhibits slow Na+ channels
2) Inhibits T-type Ca2+ channels
3) Inhibits glutamate release
4) Weak carbonic anhydrase inhibitory effect

178
Q

Zonisamide’s place in therapy?

A

Adjunctive treatment of focal-onset seizures and may be considered first-line.

179
Q

Can Zonisamide be given in pregnancy and lactation?

A

NO, it crosses the placenta

180
Q

Which Zonisamide adverse reactions are concentration-dependent?

A

1) Dizziness
2) Sedation
3) Cognitive impairment
4) Nausea

181
Q

Which Zonisamide adverse reactions are idiosyncratic?

A

1) Rash
2) Metabolic acidosis
3) Oligohydrosis

182
Q

Which Zonisamide adverse reactions are chronic?

A

1) Kidney stones
2) Weight loss